Huntleigh Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$654K Buy
7,205
+79
+1% +$7.21K 0.09% 173
2026
Q1
$732K Sell
7,126
-16,139
-69% -$1.82M 0.13% 146
2025
Q4
$2.91M Buy
23,265
+1,692
+8% +$216K 0.49% 53
2025
Q3
$2.89M Buy
21,573
+1,119
+5% +$147K 0.49% 48
2025
Q2
$2.78M Buy
20,454
+3,644
+22% +$481K 0.54% 44
2025
Q1
$2.23M Buy
16,810
+360
+2% +$45.8K 0.37% 60
2024
Q4
$1.86M Buy
+16,450
New +$1.9M 0.4% 60

Other funds holding ABT

Huntleigh Advisors's ABT Position: Q2 2026 in Review

Huntleigh Advisors increased its Abbott (ABT) stake by 1.1% in Q2 2026, buying an estimated $7.21K and bringing the position to 7,205 shares worth $654K. The position accounts for 0.09% of the portfolio, ranked #173.

Huntleigh Advisors first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.91M in Q4 2025. 2,964 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Huntleigh Advisors held 7,205 shares of Abbott worth $654K as of Q2 2026.
  • Huntleigh Advisors bought 79 Abbott shares in Q2 2026, an estimated $7.21K.
  • Abbott made up 0.09% of Huntleigh Advisors's portfolio in Q2 2026, its #173 holding.
  • Huntleigh Advisors first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Huntleigh Advisors's Abbott position peaked at $2.91M in Q4 2025.
  • 2,964 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Huntleigh Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.